Pasi A. Janne, MD, Ph.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Pasi A. Janne, MD, Ph.D., Dana-Farber Cancer Institute

Caption

A new study by researchers including Dr. Pasi A. Janne reports first success of targeted therapy in most common genetic subtype of non-small cell lung cancer

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.